Stock listing
TNGX Stock Price, News, Filings & Events — Tango Therapeutics, Inc.
Selected listing: TNGX · BOATS · USD · US
This page tracks Tango Therapeutics, Inc.'s TNGX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TNGX:BOATS. TNGX:BOATS is the stock-level entry point for investors researching Tango Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Tango Therapeutics, Inc. (TNGX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

- Ticker
- TNGX:BOATS
- Asset type
- Stock
- Market cap
- $3.94B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Tango Therapeutics, Inc. TNGX:BOATS stock context
This page tracks Tango Therapeutics, Inc.'s TNGX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TNGX:BOATS. TNGX:BOATS is the stock-level entry point for investors researching Tango Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Tango Therapeutics, Inc. (TNGX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Tango Therapeutics, Inc.
Tango Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
September 1, 2026
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
August 11, 2026
Tango Therapeutics Appoints Robert Azelby to Board of Directors
June 22, 2026
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
June 9, 2026
Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer
June 8, 2026
Research Tango Therapeutics, Inc.
Tango Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for TNGX:BOATS.
Tango Therapeutics, Inc. company profile
View the public company page for Tango Therapeutics, Inc. on 6ix.
Tango Therapeutics, Inc. news
Read company news and market updates connected to Tango Therapeutics, Inc..
Tango Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Tango Therapeutics, Inc..